{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:37Z","timestamp":1790380057271,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005620","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000}}],"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G051812N"],"award-info":[{"award-number":["G051812N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12I0317N"],"award-info":[{"award-number":["12I0317N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["TT-ZAPBOF 33049"],"award-info":[{"award-number":["TT-ZAPBOF 33049"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005620","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T18:03:03Z","timestamp":1494871383000},"page":"e0005620","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum"],"prefix":"10.1371","volume":"11","author":[{"given":"Sarah","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Van den Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien","family":"Mabille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Delputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-3202","authenticated-orcid":true,"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"PD Ready","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"17","key":"ref2","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s40265-013-0133-0","article-title":"Therapeutic options for visceral leishmaniasis","volume":"73","author":"B Monge-Maillo","year":"2013","journal-title":"Drugs"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"J Chakravarty","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"10","key":"ref4","first-page":"664","article-title":"Kala-azar elimination programme in India","volume":"106","author":"GP Dhillon","year":"2008","journal-title":"J Indian Med Assoc"},{"issue":"192","key":"ref5","first-page":"645","article-title":"The treatment of visceral leishmaniasis: safety and efficacy","volume":"52","author":"RK Jha","year":"2013","journal-title":"JNMAJ Nepal Med Assoc"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"S Sundar","year":"2010","journal-title":"New Engl J Med"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(13)70118-9","article-title":"Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study","volume":"2","author":"D Mondal","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"9764","key":"ref8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"TP Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"<italic>Leishmania<\/italic> resistance to miltefosine associated with genetic marker","volume":"18","author":"S Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00436-014-3835-7","article-title":"Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of <italic>Leishmania donovani<\/italic> and <italic>L<\/italic>. <italic>infantum<\/italic>","volume":"113","author":"S Hendrickx","year":"2014","journal-title":"Parasitol Res"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"S Srivastava","year":"2017","journal-title":"Parasites & vectors"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"e1664","DOI":"10.1371\/journal.pntd.0001664","article-title":"Experimental induction of paromomycin resistance in antimony-resistant strains of <italic>L<\/italic>. <italic>donovani<\/italic>: outcome dependent on <italic>in vitro<\/italic> selection protocol","volume":"6","author":"S Hendrickx","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00707-15","article-title":"<italic>In Vivo<\/italic> Selection of Paromomycin and Miltefosine Resistance in <italic>Leishmania donovani<\/italic> and <italic>L<\/italic>. <italic>infantum<\/italic> in a Syrian Hamster Model","volume":"59","author":"S Hendrickx","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1051\/parasite\/1998052167","article-title":"Development and characterization of paromomycin-resistant <italic>Leishmania donovani<\/italic> promastigotes","volume":"5","author":"M Maarouf","year":"1998","journal-title":"Parasite"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.01574-13","article-title":"Elucidation of cellular mechanisms involved in experimental paromomycin resistance in <italic>Leishmania donovani<\/italic>","volume":"58","author":"V Bhandari","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","article-title":"Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in <italic>Leishmania infantum<\/italic>","author":"S Hendrickx","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"<italic>In vitro<\/italic> susceptibilities of <italic>Leishmania donovani<\/italic> promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"M Vermeersch","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"K Seifert","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","first-page":"407","article-title":"Drug Resistance in <italic>Leishmania<\/italic> Parasites","author":"L Maes","year":"2013"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00436-015-4460-9","article-title":"Intracellular amastigote replication may not be required for successful <italic>in vitro<\/italic> selection of miltefosine resistance in <italic>Leishmania infantum<\/italic>","volume":"114","author":"S Hendrickx","year":"2015","journal-title":"Parasitol Res"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"S Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of <italic>Leishmania donovani<\/italic>","volume":"56","author":"B Purkait","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"9764","key":"ref24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"e0005171","DOI":"10.1371\/journal.pntd.0005171","article-title":"Different Mutations in a P-type ATPase Transporter in <italic>Leishmania<\/italic> Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms","volume":"10","author":"C Fernandez-Prada","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of <italic>Leishmania<\/italic> from Peru and Nepal to miltefosine","volume":"73","author":"V Yardley","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0074-02762011000400015","article-title":"The <italic>in vitro<\/italic> leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant <italic>Leishmania<\/italic> species of Brazil","volume":"106","author":"E Morais-Teixeira","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"e2999","DOI":"10.1371\/journal.pntd.0002999","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> miltefosine susceptibility of a <italic>Leishmania amazonensis<\/italic> isolate from a patient with diffuse cutaneous leishmaniasis","volume":"8","author":"AC Coelho","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"e2871","DOI":"10.1371\/journal.pntd.0002871","article-title":"Miltefosine and antimonial drug susceptibility of <italic>Leishmania Viannia<\/italic> species and populations in regions of high transmission in Colombia","volume":"8","author":"OL Fernandez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.01023-13","article-title":"Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by <italic>Leishmania<\/italic> subgenus <italic>Viannia<\/italic> species","volume":"58","author":"R Obonaga","year":"2014","journal-title":"Antimicrob Agents Chemotherapy"},{"issue":"12","key":"ref31","first-page":"e1974","article-title":"<italic>Leishmania donovani<\/italic> develops resistance to drug combinations","volume":"6","author":"R Garcia-Hernandez","year":"2012","journal-title":"PLoSNeglTropDis"},{"issue":"5","key":"ref32","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management","volume":"3","author":"S Sundar","year":"2007","journal-title":"Ther Clin Risk Manag"},{"issue":"25","key":"ref33","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for Visceral leishmaniasis in India","volume":"356","author":"S Sundar","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.exppara.2010.09.003","article-title":"Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis","volume":"127","author":"SA Sane","year":"2011","journal-title":"Exp Parasitol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"K Seifert","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","article-title":"Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome","author":"S Hendrickx","year":"2015","journal-title":"J Antimicrob Chemother"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005620","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:28:37Z","timestamp":1588973317000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005620"}},"subtitle":[],"editor":[{"given":"Charles L.","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005620","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005620","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}